Efficacy, safety of atropine for the treatment of pediatric nearsightedness progression over 3 years

JAMA Ophthalmology

2023-06-01

(Press-News.org) About The Study: The efficacy and safety observed in this randomized clinical trial suggest that low-dose atropine may provide a treatment option for childhood myopia progression.

Authors: Karla Zadnik, O.D., Ph.D., of the Ohio State University College of Optometry in Columbus, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaophthalmol.2023.2097)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2023.2097?guestAccessKey=cefa1859-d64c-478f-991c-4cd69da0a3a6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060123

END

ELSE PRESS RELEASES FROM THIS DATE:

Personalizing prostate cancer screening may improve the accuracy of detection

2023-06-01

The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a multi-center study led by UC San Francisco and Stanford University. In a study publishing June 1, 2023 in Nature Medicine, UCSF researchers and their collaborators conducted a large genome-wide association study of PSA in more than 95,000 men without diagnosed prostate cancer, which identified over 80 novel PSA-associated variants. They set ...

NIH’s ComboMATCH initiative will test new drug combinations guided by tumor biology

2023-06-01

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations. Known as the Combination Therapy Platform Trial with Molecular Analysis for Therapy Choice (ComboMATCH), the initiative is the largest of its kind to test combinations of cancer drugs guided by tumor biology. The endeavor aims to identify promising treatments that can advance to larger, more definitive clinical ...

High-resolution images reveal workings of a bacterial RNA riboswitch, a promising new target for antibiotics

2023-06-01

Image To prevent a global health crisis, scientists around the world are searching for ways to fight bacteria that can evade the current arsenal of antibiotics. A promising target for new and improved antibiotics are riboswitches, small stretches of RNA that regulate a process necessary for the production of proteins by the bacterial cell. Riboswitches are found almost exclusively in bacteria and could be targeted with antibiotics so that animals or humans are unaffected. With a full understanding of how riboswitches work, researchers may be able to develop drugs that disrupt the cellular machinery ...

University College Dublin researcher receives ERC funding to unlock insights into pig-to-human heart transplants

2023-06-01

Thursday 1st June: Dr Philip Cardiff, Associate Professor at University College Dublin's School of Mechanical and Materials Engineering, has received a European Research Council (ERC) Consolidator grant of €2 million for his 5-year project XenoSim. With the support of this award, Dr Cardiff will develop advanced computational techniques that can provide unprecedented insights into the cutting-edge realm of pig-to-human heart transplants ERC Consolidator Grants are awarded to help excellent scientists, ...

SISAQOL-IMI: Setting standards for the use of patient-reported outcome data in cancer trials

2023-06-01

Brussels, 1 June 2023 – Today, the European Organisation for Research and Treatment of Cancer (EORTC) is excited to share the publication of the first consensus paper by the SISAQOL-IMI Consortium1. The paper provides an overview of the stakeholders’ views on the need for SISAQOL-IMI and the agreed priority set of patient-reported outcome (PRO) objectives that the Consortium will produce international consensus-based recommendations on. The Setting International Standards in Analysing ...

First soil map of terrestrial and blue carbon highlights need for conservation

2023-06-01

New Curtin University research has identified the most carbon-rich soils in Australia are in areas that are most threatened by human activities and climate change, including Eucalypt and mangrove forests, and woodland and grassland areas that cover large parts of the country’s interior. Lead researcher Dr Lewis Walden from Curtin’s Soil & Landscape Science in the School of Molecular and Life Sciences said the findings highlighted the need to protect key terrestrial and coastal marine ecosystems, which play an important contributing role in national strategies to mitigate climate change. “Using multiscale machine ...

Tiny video capsule shows promise as an alternative to endoscopy

2023-06-01

For Embargoed Release: June 1, 2023 at 9:00 am Eastern Time USA Media Contacts: Kathy Fackelmann, kfackelmann@gwu.edu WASHINGTON (June 1, 2023)—While ingestible video capsule endoscopes have been around for many years, the capsules have been limited by the fact that they could not be controlled by physicians. They moved passively, driven only by gravity and the natural movement of the body. Now, according to a first-of-its-kind research study at George Washington University, physicians can remotely drive a miniature video ...

National Comprehensive Cancer Network joins collaboration to improve standards in cancer care for Vietnam

2023-06-01

PHILADELPHIA, UNITED STATES & HANOI, VIETNAM [June 1, 2023] — The National Comprehensive Cancer Network® (NCCN®)—a not-for-profit alliance of leading cancer centers in the United States—today announced the signing of a Memo of Understanding (MOU) with Vietnam National Cancer Hospital (“K Hospital”) and the Vietnam Cancer Association to work together to improve standards for cancer care throughout the country. Five delegates from NCCN visited Hanoi May 24-26 to sign the MOU and pilot the creation of NCCN Harmonized Guidelines™ for Vietnam. “We are honored to collaborate with in-country experts to develop and validate Vietnamese harmonizations ...

Industrially applied and relevant transformations of 1,3-butadiene using homogeneous catalysts

2023-06-01

The use of 1,3-butadiene as a cheap and abundant raw material for new applications has attracted more interest in recent decades, specifically in the chemical industry. The review covers several important homogeneously catalyzed processes and technologies that are currently used or have the potential to produce fine and bulk chemicals from 1,3-butadiene. This article focuses specifically on the application of homogeneous catalysts and presents representative examples for the readers. For example, palladium-catalyzed telomerization of 1,3-butadiene offers versatile platform chemicals for ...

Ticks prove resilient to extreme temperatures

2023-06-01

PULLMAN, Wash. — Tick season is here, along with the increased danger of Lyme disease, and it turns out the tiny arachnids are even tougher than scientists previously thought. A recent study in Ecological Monographs shows blacklegged ticks (Ixodes scapularis) are actually really good at surviving extreme cold and heat in nature. Previous lab research suggests that even short periods of especially warm or cold conditions should easily kill ticks, but the Washington State University-led analysis reveals this is only the case for larval ticks in the environment. Instead, ...

Wiley advances Knowitall Solutions with new trendfinder application for user-friendly chemometric analysis and additional enhancements to analytical workflows

Efficacy, safety of atropine for the treatment of pediatric nearsightedness progression over 3 years

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: